![Jeremy Skillington](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jeremy Skillington
Amministratore Delegato presso POOLBEG PHARMA PLC
Patrimonio netto: 152 364 $ in data 31/05/2024
Posizioni attive di Jeremy Skillington
Società | Posizione | Inizio | Fine |
---|---|---|---|
POOLBEG PHARMA PLC | Direttore/Membro del Consiglio | 01/05/2021 | - |
Amministratore Delegato | 01/05/2021 | - | |
TriMod Therapeutics Ltd.
![]() TriMod Therapeutics Ltd. BiotechnologyHealth Technology TriMod Therapeutics Ltd develops novel platform technologies to treat cancer and autoimmune diseases. It offers TriMoVac technology that enhances the patients' immune response to the tumour and promotes its eradication by attenuating its' immune subversion strategies. The company was founded by Kingston Mills and Jeremy Skillingtonand in 2011 is headquartered in Dublin, Ireland. | Amministratore Delegato | 01/01/2011 | - |
Fondatore | 01/01/2011 | - |
Storia della carriera di Jeremy Skillington
Precedenti posizioni note di Jeremy Skillington
Società | Posizione | Inizio | Fine |
---|---|---|---|
Opsona Therapeutics Ltd.
![]() Opsona Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Opsona Therapeutics Ltd. operates as a immunology drug development company. It focuses on novel therapeutics and specializes in the prevention and treatment of solid organ transplantation, cancer, diabetes, autoimmune, inflammatory and Alzheimer’s diseases. The firm developed OPN-305, an antibody to reduce pro-inflammatory cytokine production, which is now at the clinical testing phase. The company was founded by Luke O'Neill, Kingston Mills and Dermot Kelleher in 2004 and is headquartered Dublin, Ireland. | Corporate Officer/Principal | 02/12/2009 | 01/11/2010 |
Academia, Inc.
![]() Academia, Inc. Internet Software/ServicesTechnology Services Academia, Inc. develops and provides social sharing platform for academic researchers. Its platform enables researchers to share their research, monitor deep analytics, and track the research of academics they follow. The company was founded by Richard Price in September 2008 and is headquartered in San Francisco, CA. | Corporate Officer/Principal | - | - |
Genentech, Inc.
![]() Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - | - |
Formazione di Jeremy Skillington
National University of Ireland | Doctorate Degree |
Statistiche
Distribuzione geografica
Irlanda | 4 |
Stati Uniti | 3 |
2 |
Posizioni
Corporate Officer/Principal | 3 |
Chief Executive Officer | 2 |
Doctorate Degree | 1 |
Settori
Health Technology | 4 |
Consumer Services | 2 |
Technology Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 5 |
---|---|
Opsona Therapeutics Ltd.
![]() Opsona Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Opsona Therapeutics Ltd. operates as a immunology drug development company. It focuses on novel therapeutics and specializes in the prevention and treatment of solid organ transplantation, cancer, diabetes, autoimmune, inflammatory and Alzheimer’s diseases. The firm developed OPN-305, an antibody to reduce pro-inflammatory cytokine production, which is now at the clinical testing phase. The company was founded by Luke O'Neill, Kingston Mills and Dermot Kelleher in 2004 and is headquartered Dublin, Ireland. | Health Technology |
Genentech, Inc.
![]() Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
TriMod Therapeutics Ltd.
![]() TriMod Therapeutics Ltd. BiotechnologyHealth Technology TriMod Therapeutics Ltd develops novel platform technologies to treat cancer and autoimmune diseases. It offers TriMoVac technology that enhances the patients' immune response to the tumour and promotes its eradication by attenuating its' immune subversion strategies. The company was founded by Kingston Mills and Jeremy Skillingtonand in 2011 is headquartered in Dublin, Ireland. | Health Technology |
Academia, Inc.
![]() Academia, Inc. Internet Software/ServicesTechnology Services Academia, Inc. develops and provides social sharing platform for academic researchers. Its platform enables researchers to share their research, monitor deep analytics, and track the research of academics they follow. The company was founded by Richard Price in September 2008 and is headquartered in San Francisco, CA. | Technology Services |
Poolbeg Pharma Plc |
- Borsa valori
- Insiders
- Jeremy Skillington
- Esperienza